In addition to high early IFN responses, moderate COVID-19 is associated with increased plasma levels of a core of pro-inflammatory cytokines, chemokines and growth factors (e.g., IL-1a, IL-1β, IFNα, IL-12p70, and IL-17A) that are effectively resolved during infection10. The gene discussed is IL17A; the disease is COVID-19.